<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To describe the demographics and the most important <z:hpo ids='HP_0011009'>acute</z:hpo> clinical complications in patients undergoing bone marrow transplantation in the Pediatric <z:hpo ids='HP_0002664'>Oncology</z:hpo> Unit at Hospital de Cl√≠nicas de Porto Alegre, Brazil </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: A retrospective analysis was performed including 41 patients treated between August 1997 and June 2002 </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty patients received allogeneic transplants (AG) and 21 received autologous transplants (AT) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The mean age of AG patients was 8.9 +/- 5.4 years </plain></SENT>
<SENT sid="4" pm="."><plain>Twelve patients were male </plain></SENT>
<SENT sid="5" pm="."><plain>Stem cell sources were: bone marrow in 12 patients; peripheral blood in five; and unrelated cord blood in three </plain></SENT>
<SENT sid="6" pm="."><plain>The diseases were <z:hpo ids='HP_0006721'>acute lymphoid leukemia</z:hpo> in seven patients; <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> in four; <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> in two; <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> in two; Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in one; <z:hpo ids='HP_0004430'>severe combined immunodeficiency</z:hpo> in one; Chediaki-Higashi syndrome in one; Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> in one; and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in one </plain></SENT>
<SENT sid="7" pm="."><plain>One patient developed grade II <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host-disease</z:e> (GVHD), and three patients had grade IV GVHD </plain></SENT>
<SENT sid="8" pm="."><plain>Three patients developed <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD </plain></SENT>
<SENT sid="9" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> of them, the cell source was peripheral blood </plain></SENT>
<SENT sid="10" pm="."><plain>Survival in this group was 70.0 +/- 10.3% </plain></SENT>
<SENT sid="11" pm="."><plain>The main cause of <z:hpo ids='HP_0011420'>death</z:hpo> was GVHD in three patients and <z:hpo ids='HP_0100806'>sepsis</z:hpo> in another three </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:hpo ids='HP_0011420'>deaths</z:hpo> occurred before day 100 </plain></SENT>
<SENT sid="13" pm="."><plain>One of the patients who received unrelated cord blood is alive 3.5 years after the transplantation </plain></SENT>
<SENT sid="14" pm="."><plain>In AG patients, mean age was 8.7 +/- 4.3 years </plain></SENT>
<SENT sid="15" pm="."><plain>Eleven patients were male </plain></SENT>
<SENT sid="16" pm="."><plain>The stem cell sources were: peripheral blood in 16; bone marrow in three; and peripheral blood + bone marrow in two </plain></SENT>
<SENT sid="17" pm="."><plain>The diseases were: <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> in five patients; Ewing's <z:hpo ids='HP_0100242'>sarcoma</z:hpo> family <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in four; <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> in three; <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> in three; non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in one; <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo> in two; neuroectodermic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> of the central <z:mp ids='MP_0008912'>nervous</z:mp> system in two; <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> in one </plain></SENT>
<SENT sid="18" pm="."><plain>Survival in this group was 59.4 +/- 11.7% </plain></SENT>
<SENT sid="19" pm="."><plain>Five patients died due to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> relapse, two patients due to <z:hpo ids='HP_0100806'>sepsis</z:hpo> and one patient died in remission 20 months after bone marrow transplantation due to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="20" pm="."><plain>In the whole group, the most common toxicities were <z:hpo ids='HP_0002013'>vomiting</z:hpo>, mucositis, <z:hpo ids='HP_0002014'>diarrhea</z:hpo> and <z:hpo ids='HP_0002027'>abdominal pain</z:hpo> </plain></SENT>
<SENT sid="21" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infections</z:e> were recorded in 58.5% of the patients </plain></SENT>
<SENT sid="22" pm="."><plain>In 46.9%, at least one pathogen was isolated in the blood culture </plain></SENT>
<SENT sid="23" pm="."><plain>The time required for neutrophil and platelet engraftment was correlated to the number of hematopoietic stem cell infused </plain></SENT>
<SENT sid="24" pm="."><plain>CONCLUSION: The overall survival in our patients is similar to that reported in the literature </plain></SENT>
<SENT sid="25" pm="."><plain>We did not find differences between AT and AG patients regarding <z:hpo ids='HP_0011009'>acute</z:hpo> toxicities and <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
</text></document>